Specific uptake of molecular biomarkers can be achieved using radiolabeled targeting agents such as antibodies, directed against tumor-associated antigens like epidermal growth factor receptor (EGFR) [2], human epidermal growth factor receptor 2 (HER2), and many others. The gene discussed is EGFR; the disease is neoplasm.